Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Eli Lilly and Company, Common Stock

LLY

NYQ

$857.47

+$8.57

(1.01%)

Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$815.93B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

126.44

Volume

This is the total number of shares traded during the most recent trading day.

3.77M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

3.11M

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.61%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.41

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$443.25 L

$966.1 H

$857.47

About Eli Lilly and Company, Common Stock

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time Frame	LLY	Sector	S&P500
1-Week Return	-9.45%	-0.78%	-1.28%
1-Month Return	-3.07%	0.89%	1.37%
3-Month Return	18.44%	6.29%	12.01%
6-Month Return	37.1%	6.29%	15.36%
1-Year Return	90.76%	12.68%	23.24%
3-Year Return	279.15%	21.13%	36.17%
5-Year Return	764.96%	74.73%	101.78%
10-Year Return	1552.29%	182.71%	236.91%

Time Frame	LLY	Sector	S&P500
1-Week Return	-99.44%	-33.52%	-48.92%
1-Month Return	-31.57%	11.38%	18.00%
3-Month Return	98.64%	28.07%	58.40%
6-Month Return	89.62%	13.17%	33.61%
1-Year Return	90.76%	12.68%	23.24%
3-Year Return	55.93%	6.60%	10.84%
5-Year Return	53.96%	11.81%	15.07%
10-Year Return	32.38%	10.95%	12.91%

Financials

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Revenue	22.32B	24.54B	28.32B	28.54B	34.12B	[{"date":"2019-12-31","value":65.41,"profit":true},{"date":"2020-12-31","value":71.91,"profit":true},{"date":"2021-12-31","value":82.99,"profit":true},{"date":"2022-12-31","value":83.64,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	4.72B	5.48B	7.31B	6.63B	6.58B	[{"date":"2019-12-31","value":64.56,"profit":true},{"date":"2020-12-31","value":74.98,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":90.66,"profit":true},{"date":"2023-12-31","value":89.92,"profit":true}]
Gross Profit	17.60B	19.06B	21.01B	21.91B	27.55B	[{"date":"2019-12-31","value":63.88,"profit":true},{"date":"2020-12-31","value":69.18,"profit":true},{"date":"2021-12-31","value":76.25,"profit":true},{"date":"2022-12-31","value":79.54,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin	78.85%	77.66%	74.18%	76.77%	80.73%	[{"date":"2019-12-31","value":97.67,"profit":true},{"date":"2020-12-31","value":96.19,"profit":true},{"date":"2021-12-31","value":91.88,"profit":true},{"date":"2022-12-31","value":95.1,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	11.81B	12.21B	13.46B	13.63B	17.22B	[{"date":"2019-12-31","value":68.57,"profit":true},{"date":"2020-12-31","value":70.88,"profit":true},{"date":"2021-12-31","value":78.14,"profit":true},{"date":"2022-12-31","value":79.15,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	4.97B	6.06B	6.36B	7.13B	10.33B	[{"date":"2019-12-31","value":48.18,"profit":true},{"date":"2020-12-31","value":58.67,"profit":true},{"date":"2021-12-31","value":61.57,"profit":true},{"date":"2022-12-31","value":69.03,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	(28.60M)	845.30M	(516.00M)	(589.70M)	(4.08B)	[{"date":"2019-12-31","value":-3.38,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-61.04,"profit":false},{"date":"2022-12-31","value":-69.76,"profit":false},{"date":"2023-12-31","value":-483.04,"profit":false}]
Pre-Tax Income	5.27B	7.23B	6.16B	6.81B	6.55B	[{"date":"2019-12-31","value":72.84,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":85.14,"profit":true},{"date":"2022-12-31","value":94.14,"profit":true},{"date":"2023-12-31","value":90.66,"profit":true}]
Income Taxes	628.00M	1.04B	573.80M	561.60M	1.31B	[{"date":"2019-12-31","value":47.79,"profit":true},{"date":"2020-12-31","value":78.85,"profit":true},{"date":"2021-12-31","value":43.66,"profit":true},{"date":"2022-12-31","value":42.73,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes	4.64B	6.19B	5.58B	6.24B	5.24B	[{"date":"2019-12-31","value":74.27,"profit":true},{"date":"2020-12-31","value":99.18,"profit":true},{"date":"2021-12-31","value":89.38,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":83.92,"profit":true}]

Income From Continuous Operations	4.64B	6.19B	5.58B	6.24B	5.24B	[{"date":"2019-12-31","value":74.27,"profit":true},{"date":"2020-12-31","value":99.18,"profit":true},{"date":"2021-12-31","value":89.38,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":83.92,"profit":true}]
Income From Discontinued Operations	3.68B	-	-	-	-	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	4.64B	6.19B	5.58B	6.24B	5.24B	[{"date":"2019-12-31","value":74.27,"profit":true},{"date":"2020-12-31","value":99.18,"profit":true},{"date":"2021-12-31","value":89.38,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":83.92,"profit":true}]

EPS (Diluted)	6.04	7.93	8.17	8.09	6.32	[{"date":"2019-12-31","value":73.93,"profit":true},{"date":"2020-12-31","value":97.06,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.02,"profit":true},{"date":"2023-12-31","value":77.36,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Revenue	-	9.95%	15.40%	0.79%	19.56%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":50.86,"profit":true},{"date":"2021-12-31","value":78.72,"profit":true},{"date":"2022-12-31","value":4.03,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	-	16.14%	33.36%	(9.34%)	(0.81%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":48.38,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-27.99,"profit":false},{"date":"2023-12-31","value":-2.43,"profit":false}]
Gross Profit	-	8.29%	10.23%	4.31%	25.72%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":32.21,"profit":true},{"date":"2021-12-31","value":39.76,"profit":true},{"date":"2022-12-31","value":16.77,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin	-	(1.51%)	(4.48%)	3.50%	5.16%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-29.32,"profit":false},{"date":"2021-12-31","value":-86.9,"profit":false},{"date":"2022-12-31","value":67.85,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	-	3.37%	10.25%	1.29%	26.35%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":12.8,"profit":true},{"date":"2021-12-31","value":38.88,"profit":true},{"date":"2022-12-31","value":4.9,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	-	21.79%	4.94%	12.12%	44.87%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":48.55,"profit":true},{"date":"2021-12-31","value":11,"profit":true},{"date":"2022-12-31","value":27,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	(3055.59%)	(161.04%)	14.28%	592.40%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-515.8,"profit":false},{"date":"2021-12-31","value":-27.18,"profit":false},{"date":"2022-12-31","value":2.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income	-	37.30%	(14.86%)	10.57%	(3.70%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-39.84,"profit":false},{"date":"2022-12-31","value":28.35,"profit":true},{"date":"2023-12-31","value":-9.92,"profit":false}]
Income Taxes	-	65.00%	(44.62%)	(2.13%)	134.01%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":48.5,"profit":true},{"date":"2021-12-31","value":-33.3,"profit":false},{"date":"2022-12-31","value":-1.59,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes	-	33.55%	(9.88%)	11.88%	(16.08%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-29.46,"profit":false},{"date":"2022-12-31","value":35.41,"profit":true},{"date":"2023-12-31","value":-47.95,"profit":false}]

Income From Continuous Operations	-	33.55%	(9.88%)	11.88%	(16.08%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-29.46,"profit":false},{"date":"2022-12-31","value":35.41,"profit":true},{"date":"2023-12-31","value":-47.95,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	33.55%	(9.88%)	11.88%	(16.08%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-29.46,"profit":false},{"date":"2022-12-31","value":35.41,"profit":true},{"date":"2023-12-31","value":-47.95,"profit":false}]

EPS (Diluted)	-	31.29%	3.03%	(0.98%)	(21.88%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":9.67,"profit":true},{"date":"2022-12-31","value":-3.13,"profit":false},{"date":"2023-12-31","value":-69.92,"profit":false}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Total Revenue	6.96B	8.31B	9.50B	9.35B	8.77B	[{"date":"2023-03-31","value":73.27,"profit":true},{"date":"2023-06-30","value":87.51,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":98.47,"profit":true},{"date":"2024-03-31","value":92.31,"profit":true}]
Cost of Revenue	1.63B	1.81B	1.86B	1.66B	1.53B	[{"date":"2023-03-31","value":87.45,"profit":true},{"date":"2023-06-30","value":97.17,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":89.19,"profit":true},{"date":"2024-03-31","value":82.49,"profit":true}]
Gross Profit	5.33B	6.50B	7.64B	7.69B	7.23B	[{"date":"2023-03-31","value":69.31,"profit":true},{"date":"2023-06-30","value":84.54,"profit":true},{"date":"2023-09-30","value":99.27,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":94.01,"profit":true}]
Gross Margin	76.63%	78.26%	80.42%	82.26%	82.50%	[{"date":"2023-03-31","value":92.88,"profit":true},{"date":"2023-06-30","value":94.86,"profit":true},{"date":"2023-09-30","value":97.48,"profit":true},{"date":"2023-12-31","value":99.71,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]

Operating Expenses	3.73B	4.28B	4.21B	4.62B	4.61B	[{"date":"2023-03-31","value":80.89,"profit":true},{"date":"2023-06-30","value":92.76,"profit":true},{"date":"2023-09-30","value":91.26,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":99.95,"profit":true}]
Operating Income	1.49B	2.13B	450.40M	3.08B	2.62B	[{"date":"2023-03-31","value":48.54,"profit":true},{"date":"2023-06-30","value":69.06,"profit":true},{"date":"2023-09-30","value":14.63,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":85.1,"profit":true}]
Total Non-Operating Income/Expense	(32.90M)	(133.90M)	(3.00B)	(663.00M)	(217.20M)	[{"date":"2023-03-31","value":-3290000000,"profit":false},{"date":"2023-06-30","value":-13390000000,"profit":false},{"date":"2023-09-30","value":-299830000000,"profit":false},{"date":"2023-12-31","value":-66300000000,"profit":false},{"date":"2024-03-31","value":-21720000000,"profit":false}]
Pre-Tax Income	1.53B	2.09B	427.20M	2.51B	2.54B	[{"date":"2023-03-31","value":60.32,"profit":true},{"date":"2023-06-30","value":82.37,"profit":true},{"date":"2023-09-30","value":16.84,"profit":true},{"date":"2023-12-31","value":98.92,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Income Taxes	184.80M	325.70M	484.60M	319.20M	293.20M	[{"date":"2023-03-31","value":38.13,"profit":true},{"date":"2023-06-30","value":67.21,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":65.87,"profit":true},{"date":"2024-03-31","value":60.5,"profit":true}]
Income After Taxes	1.34B	1.76B	(57.40M)	2.19B	2.24B	[{"date":"2023-03-31","value":59.96,"profit":true},{"date":"2023-06-30","value":78.61,"profit":true},{"date":"2023-09-30","value":-2.56,"profit":false},{"date":"2023-12-31","value":97.62,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]

Income From Continuous Operations	1.34B	1.76B	(57.40M)	2.19B	2.24B	[{"date":"2023-03-31","value":59.96,"profit":true},{"date":"2023-06-30","value":78.61,"profit":true},{"date":"2023-09-30","value":-2.56,"profit":false},{"date":"2023-12-31","value":97.63,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Net Income	1.34B	1.76B	(57.40M)	2.19B	2.24B	[{"date":"2023-03-31","value":59.96,"profit":true},{"date":"2023-06-30","value":78.61,"profit":true},{"date":"2023-09-30","value":-2.56,"profit":false},{"date":"2023-12-31","value":97.63,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]

EPS (Diluted)	1.62	2.11	0.10	2.49	2.58	[{"date":"2023-03-31","value":62.79,"profit":true},{"date":"2023-06-30","value":81.78,"profit":true},{"date":"2023-09-30","value":3.88,"profit":true},{"date":"2023-12-31","value":96.51,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Total Revenue	-	19.43%	14.27%	(1.53%)	(6.26%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":73.48,"profit":true},{"date":"2023-12-31","value":-7.87,"profit":false},{"date":"2024-03-31","value":-32.22,"profit":false}]
Cost of Revenue	-	11.11%	2.92%	(10.81%)	(7.51%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":26.25,"profit":true},{"date":"2023-12-31","value":-97.33,"profit":false},{"date":"2024-03-31","value":-67.61,"profit":false}]
Gross Profit	-	21.96%	17.43%	0.73%	(5.99%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":79.36,"profit":true},{"date":"2023-12-31","value":3.33,"profit":true},{"date":"2024-03-31","value":-27.27,"profit":false}]
Gross Margin	-	2.12%	2.76%	2.30%	0.29%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":76.92,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":83.12,"profit":true},{"date":"2024-03-31","value":10.43,"profit":true}]

Operating Expenses	-	14.66%	(1.61%)	9.57%	(0.05%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-10.97,"profit":false},{"date":"2023-12-31","value":65.28,"profit":true},{"date":"2024-03-31","value":-0.32,"profit":false}]
Operating Income	-	42.28%	(78.81%)	583.41%	(14.90%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":7.25,"profit":true},{"date":"2023-09-30","value":-13.51,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":-2.55,"profit":false}]
Total Non-Operating Income/Expense	-	306.99%	2139.21%	(77.89%)	(67.24%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":14.35,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-3.64,"profit":false},{"date":"2024-03-31","value":-3.14,"profit":false}]
Pre-Tax Income	-	36.56%	(79.55%)	487.27%	1.09%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":7.5,"profit":true},{"date":"2023-09-30","value":-16.33,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":0.22,"profit":true}]
Income Taxes	-	76.24%	48.79%	(34.13%)	(8.15%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":63.99,"profit":true},{"date":"2023-12-31","value":-44.77,"profit":false},{"date":"2024-03-31","value":-10.68,"profit":false}]
Income After Taxes	-	31.10%	(103.26%)	(3914.63%)	2.43%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-331.98,"profit":false},{"date":"2023-12-31","value":-12586.16,"profit":false},{"date":"2024-03-31","value":7.83,"profit":true}]

Income From Continuous Operations	-	31.10%	(103.26%)	(3914.81%)	2.43%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-331.98,"profit":false},{"date":"2023-12-31","value":-12586.72,"profit":false},{"date":"2024-03-31","value":7.81,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Net Income	-	31.10%	(103.26%)	(3914.81%)	2.43%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-331.98,"profit":false},{"date":"2023-12-31","value":-12586.72,"profit":false},{"date":"2024-03-31","value":7.81,"profit":true}]

EPS (Diluted)	-	30.25%	(95.26%)	2390.00%	3.61%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":1.27,"profit":true},{"date":"2023-09-30","value":-3.99,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":0.15,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Assets
Current Assets	13.71B	17.46B	18.45B	18.03B	25.73B	[{"date":"2019-12-31","value":53.29,"profit":true},{"date":"2020-12-31","value":67.87,"profit":true},{"date":"2021-12-31","value":71.72,"profit":true},{"date":"2022-12-31","value":70.1,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	25.58B	29.17B	30.35B	31.46B	38.28B	[{"date":"2019-12-31","value":66.82,"profit":true},{"date":"2020-12-31","value":76.21,"profit":true},{"date":"2021-12-31","value":79.3,"profit":true},{"date":"2022-12-31","value":82.17,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Assets	39.29B	46.63B	48.81B	49.49B	64.01B	[{"date":"2019-12-31","value":61.38,"profit":true},{"date":"2020-12-31","value":72.86,"profit":true},{"date":"2021-12-31","value":76.25,"profit":true},{"date":"2022-12-31","value":77.32,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	11.78B	12.48B	15.05B	17.14B	27.29B	[{"date":"2019-12-31","value":43.14,"profit":true},{"date":"2020-12-31","value":45.73,"profit":true},{"date":"2021-12-31","value":55.15,"profit":true},{"date":"2022-12-31","value":62.79,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	24.81B	28.33B	24.60B	21.58B	25.85B	[{"date":"2019-12-31","value":87.59,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":86.84,"profit":true},{"date":"2022-12-31","value":76.17,"profit":true},{"date":"2023-12-31","value":91.26,"profit":true}]
Total Liabilities	36.59B	40.81B	39.65B	38.71B	53.14B	[{"date":"2019-12-31","value":68.85,"profit":true},{"date":"2020-12-31","value":76.79,"profit":true},{"date":"2021-12-31","value":74.61,"profit":true},{"date":"2022-12-31","value":72.85,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	598.80M	598.20M	596.30M	594.10M	593.60M	[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":99.9,"profit":true},{"date":"2021-12-31","value":99.58,"profit":true},{"date":"2022-12-31","value":99.22,"profit":true},{"date":"2023-12-31","value":99.13,"profit":true}]
Retained Earnings	4.92B	7.83B	8.96B	10.04B	10.31B	[{"date":"2019-12-31","value":47.71,"profit":true},{"date":"2020-12-31","value":75.93,"profit":true},{"date":"2021-12-31","value":86.87,"profit":true},{"date":"2022-12-31","value":97.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Other Stockholders' Equity	3.61B	3.71B	3.77B	3.86B	4.19B	[{"date":"2019-12-31","value":86.13,"profit":true},{"date":"2020-12-31","value":88.47,"profit":true},{"date":"2021-12-31","value":89.85,"profit":true},{"date":"2022-12-31","value":92,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	2.61B	5.64B	8.98B	10.65B	10.77B	[{"date":"2019-12-31","value":24.2,"profit":true},{"date":"2020-12-31","value":52.37,"profit":true},{"date":"2021-12-31","value":83.36,"profit":true},{"date":"2022-12-31","value":98.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	39.19B	46.45B	48.63B	49.36B	63.91B	[{"date":"2019-12-31","value":61.32,"profit":true},{"date":"2020-12-31","value":72.67,"profit":true},{"date":"2021-12-31","value":76.09,"profit":true},{"date":"2022-12-31","value":77.23,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Assets
Current Assets	-	27.37%	5.67%	(2.26%)	42.65%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":64.17,"profit":true},{"date":"2021-12-31","value":13.3,"profit":true},{"date":"2022-12-31","value":-5.31,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	-	14.05%	4.05%	3.63%	21.69%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":64.78,"profit":true},{"date":"2021-12-31","value":18.69,"profit":true},{"date":"2022-12-31","value":16.73,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Assets	-	18.70%	4.66%	1.40%	29.33%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":63.76,"profit":true},{"date":"2021-12-31","value":15.89,"profit":true},{"date":"2022-12-31","value":4.78,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	6.00%	20.60%	13.85%	59.25%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":10.12,"profit":true},{"date":"2021-12-31","value":34.76,"profit":true},{"date":"2022-12-31","value":23.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	-	14.16%	(13.16%)	(12.29%)	19.81%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":71.52,"profit":true},{"date":"2021-12-31","value":-66.45,"profit":false},{"date":"2022-12-31","value":-62.04,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	-	11.54%	(2.83%)	(2.36%)	37.27%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":30.96,"profit":true},{"date":"2021-12-31","value":-7.61,"profit":false},{"date":"2022-12-31","value":-6.34,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	(0.10%)	(0.32%)	(0.37%)	(0.08%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Retained Earnings	-	59.14%	14.41%	12.10%	2.69%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":24.37,"profit":true},{"date":"2022-12-31","value":20.46,"profit":true},{"date":"2023-12-31","value":4.54,"profit":true}]
Other Stockholders' Equity	-	2.72%	1.56%	2.39%	8.69%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":31.32,"profit":true},{"date":"2021-12-31","value":17.96,"profit":true},{"date":"2022-12-31","value":27.55,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	116.41%	59.16%	18.61%	1.15%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":50.82,"profit":true},{"date":"2022-12-31","value":15.98,"profit":true},{"date":"2023-12-31","value":0.98,"profit":true}]

Total Liabilities & Shareholders Equity	-	18.51%	4.70%	1.51%	29.48%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":62.81,"profit":true},{"date":"2021-12-31","value":15.93,"profit":true},{"date":"2022-12-31","value":5.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Total Assets
Current Assets	20.81B	21.33B	23.01B	25.73B	25.19B	[{"date":"2023-03-31","value":80.89,"profit":true},{"date":"2023-06-30","value":82.92,"profit":true},{"date":"2023-09-30","value":89.43,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":97.91,"profit":true}]
Non-current Assets	32.35B	33.48B	34.91B	38.28B	38.75B	[{"date":"2023-03-31","value":83.48,"profit":true},{"date":"2023-06-30","value":86.4,"profit":true},{"date":"2023-09-30","value":90.08,"profit":true},{"date":"2023-12-31","value":98.77,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Total Assets	53.16B	54.81B	57.92B	64.01B	63.94B	[{"date":"2023-03-31","value":83.06,"profit":true},{"date":"2023-06-30","value":85.64,"profit":true},{"date":"2023-09-30","value":90.48,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":99.9,"profit":true}]

Total Liabilities
Current Liabilities	16.01B	18.91B	22.00B	27.29B	18.60B	[{"date":"2023-03-31","value":58.66,"profit":true},{"date":"2023-06-30","value":69.3,"profit":true},{"date":"2023-09-30","value":80.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":68.14,"profit":true}]
Non-current Liabilities	25.86B	24.75B	24.61B	25.85B	32.45B	[{"date":"2023-03-31","value":79.69,"profit":true},{"date":"2023-06-30","value":76.27,"profit":true},{"date":"2023-09-30","value":75.84,"profit":true},{"date":"2023-12-31","value":79.66,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Total Liabilities	41.87B	43.66B	46.61B	53.14B	51.05B	[{"date":"2023-03-31","value":78.78,"profit":true},{"date":"2023-06-30","value":82.17,"profit":true},{"date":"2023-09-30","value":87.7,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":96.05,"profit":true}]

Total Shareholders' equity
Common Stock	593.50M	593.60M	593.60M	593.60M	594.20M	[{"date":"2023-03-31","value":99.88,"profit":true},{"date":"2023-06-30","value":99.9,"profit":true},{"date":"2023-09-30","value":99.9,"profit":true},{"date":"2023-12-31","value":99.9,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Retained Earnings	10.64B	10.37B	10.31B	10.31B	12.55B	[{"date":"2023-03-31","value":84.75,"profit":true},{"date":"2023-06-30","value":82.59,"profit":true},{"date":"2023-09-30","value":82.13,"profit":true},{"date":"2023-12-31","value":82.14,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Other Stockholders' Equity	3.73B	3.89B	4.10B	4.19B	3.96B	[{"date":"2023-03-31","value":89.07,"profit":true},{"date":"2023-06-30","value":92.78,"profit":true},{"date":"2023-09-30","value":97.82,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":94.53,"profit":true}]
Total Shareholders' equity	11.19B	11.06B	11.22B	10.77B	12.81B	[{"date":"2023-03-31","value":87.34,"profit":true},{"date":"2023-06-30","value":86.35,"profit":true},{"date":"2023-09-30","value":87.58,"profit":true},{"date":"2023-12-31","value":84.08,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	53.06B	54.73B	57.83B	63.91B	63.86B	[{"date":"2023-03-31","value":83.01,"profit":true},{"date":"2023-06-30","value":85.63,"profit":true},{"date":"2023-09-30","value":90.48,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":99.91,"profit":true}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Total Assets
Current Assets	-	2.50%	7.85%	11.82%	(2.09%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":21.14,"profit":true},{"date":"2023-09-30","value":66.43,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":-17.69,"profit":false}]
Non-current Assets	-	3.50%	4.26%	9.66%	1.24%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":36.2,"profit":true},{"date":"2023-09-30","value":44.11,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":12.86,"profit":true}]
Total Assets	-	3.11%	5.66%	10.52%	(0.10%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":29.53,"profit":true},{"date":"2023-09-30","value":53.8,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":-0.93,"profit":false}]

Total Liabilities
Current Liabilities	-	18.14%	16.30%	24.07%	(31.86%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":75.38,"profit":true},{"date":"2023-09-30","value":67.72,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":-132.36,"profit":false}]
Non-current Liabilities	-	(4.29%)	(0.56%)	5.04%	25.53%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-16.79,"profit":false},{"date":"2023-09-30","value":-2.21,"profit":false},{"date":"2023-12-31","value":19.73,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Total Liabilities	-	4.29%	6.74%	14.02%	(3.95%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":30.61,"profit":true},{"date":"2023-09-30","value":48.08,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":-28.14,"profit":false}]

Total Shareholders' equity
Common Stock	-	0.02%	-	-	0.10%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":16.67,"profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Retained Earnings	-	(2.55%)	(0.57%)	0.02%	21.74%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-11.71,"profit":false},{"date":"2023-09-30","value":-2.6,"profit":false},{"date":"2023-12-31","value":0.11,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Other Stockholders' Equity	-	4.16%	5.43%	2.22%	(5.47%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":76.62,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":40.92,"profit":true},{"date":"2024-03-31","value":-100.68,"profit":false}]
Total Shareholders' equity	-	(1.13%)	1.42%	(4.00%)	18.94%	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-5.97,"profit":false},{"date":"2023-09-30","value":7.47,"profit":true},{"date":"2023-12-31","value":-21.1,"profit":false},{"date":"2024-03-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	3.15%	5.66%	10.52%	(0.09%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":29.91,"profit":true},{"date":"2023-09-30","value":53.82,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":-0.84,"profit":false}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Operating Activities
Net Operating Cash Flow	4.84B	6.50B	7.26B	7.08B	4.24B	[{"date":"2019-12-31","value":66.61,"profit":true},{"date":"2020-12-31","value":89.52,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.57,"profit":true},{"date":"2023-12-31","value":58.4,"profit":true}]

Investing Activities
Net Investing Cash Flow	(8.08B)	(2.26B)	(2.87B)	(3.76B)	(7.15B)	[{"date":"2019-12-31","value":-808290000000,"profit":false},{"date":"2020-12-31","value":-225890000000,"profit":false},{"date":"2021-12-31","value":-286750000000,"profit":false},{"date":"2022-12-31","value":-376290000000,"profit":false},{"date":"2023-12-31","value":-715270000000,"profit":false}]

Financing Activities
Net Financing Cash Flow	(2.32B)	(3.14B)	(4.13B)	(5.41B)	3.50B	[{"date":"2019-12-31","value":-66.5,"profit":false},{"date":"2020-12-31","value":-89.74,"profit":false},{"date":"2021-12-31","value":-118.19,"profit":false},{"date":"2022-12-31","value":-154.67,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	(5.66B)	1.32B	161.40M	(1.75B)	751.60M	[{"date":"2019-12-31","value":-428.97,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":12.23,"profit":true},{"date":"2022-12-31","value":-132.73,"profit":false},{"date":"2023-12-31","value":56.96,"profit":true}]

Free Cash Flow
Free Cash Flow	3.48B	4.47B	5.39B	4.60B	(3.15B)	[{"date":"2019-12-31","value":64.65,"profit":true},{"date":"2020-12-31","value":82.98,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":85.39,"profit":true},{"date":"2023-12-31","value":-58.51,"profit":false}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Operating Activities
Net Operating Cash Flow	-	34.38%	11.71%	(2.43%)	(40.15%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":34.06,"profit":true},{"date":"2022-12-31","value":-7.06,"profit":false},{"date":"2023-12-31","value":-116.77,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(72.05%)	26.94%	31.23%	90.08%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-79.98,"profit":false},{"date":"2021-12-31","value":29.91,"profit":true},{"date":"2022-12-31","value":34.66,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	34.96%	31.69%	30.87%	(164.65%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":90.66,"profit":true},{"date":"2022-12-31","value":88.31,"profit":true},{"date":"2023-12-31","value":-471,"profit":false}]

Net Change in Cash	-	(123.31%)	(87.77%)	(1185.19%)	(142.91%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	28.35%	20.51%	(14.61%)	(168.52%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":72.36,"profit":true},{"date":"2022-12-31","value":-51.54,"profit":false},{"date":"2023-12-31","value":-594.45,"profit":false}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Operating Activities
Net Operating Cash Flow	1.73B	631.90M	2.19B	(311.90M)	1.17B	[{"date":"2023-03-31","value":79.04,"profit":true},{"date":"2023-06-30","value":28.86,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-14.25,"profit":false},{"date":"2024-03-31","value":53.25,"profit":true}]

Investing Activities
Net Investing Cash Flow	(688.80M)	(459.10M)	(3.08B)	(2.92B)	(1.18B)	[{"date":"2023-03-31","value":-68880000000,"profit":false},{"date":"2023-06-30","value":-45910000000,"profit":false},{"date":"2023-09-30","value":-308050000000,"profit":false},{"date":"2023-12-31","value":-292430000000,"profit":false},{"date":"2024-03-31","value":-117760000000,"profit":false}]

Financing Activities
Net Financing Cash Flow	412.30M	(1.03B)	572.00M	3.54B	(311.30M)	[{"date":"2023-03-31","value":11.63,"profit":true},{"date":"2023-06-30","value":-29.15,"profit":false},{"date":"2023-09-30","value":16.14,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":-8.78,"profit":false}]

Net Change in Cash	1.48B	(851.40M)	(313.70M)	437.80M	(358.40M)	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-57.57,"profit":false},{"date":"2023-09-30","value":-21.21,"profit":false},{"date":"2023-12-31","value":29.6,"profit":true},{"date":"2024-03-31","value":-24.23,"profit":false}]

Free Cash Flow
Free Cash Flow	827.10M	(204.40M)	(1.81B)	(1.96B)	179.70M	[{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-24.71,"profit":false},{"date":"2023-09-30","value":-219.04,"profit":false},{"date":"2023-12-31","value":-237.34,"profit":false},{"date":"2024-03-31","value":21.73,"profit":true}]

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	TREND
Operating Activities
Net Operating Cash Flow	-	(63.49%)	246.49%	(114.25%)	(473.84%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-25.76,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-46.35,"profit":false},{"date":"2024-03-31","value":-192.23,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(33.35%)	570.99%	(5.07%)	(59.73%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-5.84,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":-0.89,"profit":false},{"date":"2024-03-31","value":-10.46,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(350.64%)	(155.35%)	519.70%	(108.78%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-67.47,"profit":false},{"date":"2023-09-30","value":-29.89,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-03-31","value":-20.93,"profit":false}]

Net Change in Cash	-	(157.57%)	(63.15%)	(239.56%)	(181.86%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":null,"profit":false},{"date":"2023-09-30","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-03-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(124.71%)	786.35%	8.35%	(109.15%)	[{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":-15.86,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":1.06,"profit":true},{"date":"2024-03-31","value":-13.88,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	LLY
Cash Ratio	0.14
Current Ratio	1.35
Quick Ratio	1.03

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	LLY
ROA (LTM)	12.60%
ROE (LTM)	50.75%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	LLY
Debt Ratio Lower is generally better. Negative is bad.	0.80
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.20
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is.	4.99

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	LLY
Trailing PE	125.02
Forward PE	60.24
P/S (TTM)	20.94
P/B	66.34
Price/FCF	4253
EV/R	21.60
EV/Ebitda	86.01
PEG	16.44

News

Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs?

At least one of the pair has a credible shot at finding a home in the market.

20 Jul, 2024 a 1:30 pm The Motley Fool

US stocks end volatile session lower in aftermath of global tech outage

A Crowdstrike software glitch caused U.S. stock declines Friday. Dow Jones, Nasdaq, S&P 500 dropped amid high volatility. Nvidia, Philadelphia SE Semiconductor Index fell. Fed targets 2% inflation. Russell 2000 declined. Strong second-quarter earnings; Tesla, Alphabet next week. Eli Lilly, Intuitive Surgical, SLB rose. Travelers, Netflix fell. Negative weekly performance. Volume down, investor anxiety up.

20 Jul, 2024 a 5:24 am Economic Times India

China approves Eli Lilly''s weight loss drug as country launches obesity awareness campaign

Eli Lilly’s tirzepatide has been approved for weight management in China, entering what’s expected to be a substantial market for GLP-1s. Tirzepatide — marketed in the … Sign up to read this article for free. Get free access to a limited …

19 Jul, 2024 a 8:57 pm EIN News Pharmaceuticals

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Morphic Holding, Inc. – MORF

NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Morphic Holding, Inc . ( Nasdaq : MORF ), relating to its proposed merger with Eli Lilly and Company. Under the terms of the agreement, Morphic Holding shareholders will receive $57.00 in cash per share they own.

19 Jul, 2024 a 6:28 pm GlobeNewswire

Eli Lilly Gets Green Light To Sell Weight-Loss Drug in China

Eli Lilly has won approval from Chinese regulators to sell its weight-loss treatment tirzepatide in the country, the company said in a social media post on Friday.

19 Jul, 2024 a 5:06 pm Investopedia

Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review

The stock market rally had some wild moves during the week. The Dow Jones and Russell 2000 jumped, but came off highs. The Nasdaq tumbled.

19 Jul, 2024 a 3:17 pm Investor''s Business Daily

Eli Lilly secures weight loss drug approval in China: How do rivals stack up?

Eli Lily''s Mounjaro, a weight management drug, has successfully received regulatory approval in China, sending its stock price up during trading today.

19 Jul, 2024 a 2:55 pm Invezz

Market mosaic: Navigating through a mixed performance landscape

Market mosaic: Navigating through a mixed performance landscape Today''s stock market presents a vibrant tapestry of performances across various sectors, illustrated vividly in the latest heatmap snapshot. As markets oscillate, understanding sectoral dynamics becomes crucial for informed investment strategies. Technology Sector: A close scrutiny The technology sector shows a divergent performance with Microsoft (MSFT) witnessing a notable decline of 1.80%, suggesting investor caution or profit-taking within the software-infrastructure field. Conversely, Apple (AAPL) sees an upturn by 0.67%, possibly reflecting confidence in consumer electronics. Semiconductor stocks like Nvidia (NVDA) and Intel (INTC) are slightly down, indicating specific stress within this sub-sector. Health and Pharmaceuticals: Booming potential Pharmaceutical giants like Eli Lilly (LLY) have soared, with an impressive increase of 1.98%, signaling strong investor confidence possibly spurred by promising developments or financial results.

19 Jul, 2024 a 1:46 pm Forexlive

Eli Lillys Weight Loss Drug Approved For Use In China

U.S. pharmaceutical company Eli Lilly & Co.s (LLY) weight loss medication called Mounjaro has been approved for use in China. Chinese regulators gave approval To Eli Lillys weight less drug a month after approving the weight loss medication of rival pharmaceutical giant Novo Nordisk (NVO). Chinas National Medical Products Administration approved Eli Lillys monthly injection for long-term weight loss. The regulator had previously approved the drug for treating diabetes. Chinas health authority estimates that half of the countrys 1.4 billion citizens are overweight, and the Chinese market represents a huge opportunity for both Eli Lilly and Novo Nordisk. Specifically, Chinas National Health Commission estimates that 34% of the population is overweight and 16% are severely overweight or obese. Approval to sell its weight loss drug in China comes at a pivotal time for EIi Lilly with illegal and generic versions of its drugs flooding the global marketplace. At the same time, competing pharmaceutical companies are pushing their own weight loss drugs through late-stage clinical trials in hopes of regulatory approval as soon as 2025.

19 Jul, 2024 a 1:46 pm Baystreet Canada

10 things to watch in the stock market Friday, including tech rotation and Eli Lilly approval

The S&P 500 and Nasdaq Composite were little unchanged in premarket trading as tech stocks look to stabilize after a rotation from 2024 winners.

19 Jul, 2024 a 1:08 pm CNBC

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Eli Lilly and Company share price today?

Eli Lilly and Company (LLY) share price today is $857.47

Can Indians buy Eli Lilly and Company shares?

Yes, Indians can buy shares of Eli Lilly and Company (LLY) on Vested. To buy Eli Lilly and Company from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LLY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Eli Lilly and Company be purchased?

Yes, you can purchase fractional shares of Eli Lilly and Company (LLY) via the Vested app. You can start investing in Eli Lilly and Company (LLY) with a minimum investment of $1.

How to invest in Eli Lilly and Company shares from India?

You can invest in shares of Eli Lilly and Company (LLY) via Vested in three simple steps:

Click on Sign Up or Invest in LLY stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Eli Lilly and Company shares

What is Eli Lilly and Company 52-week high and low stock price?

The 52-week high price of Eli Lilly and Company (LLY) is $966.1. The 52-week low price of Eli Lilly and Company (LLY) is $443.25.

What is Eli Lilly and Company price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Eli Lilly and Company (LLY) is 126.44

What is Eli Lilly and Company price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Eli Lilly and Company (LLY) is 66.34

What is Eli Lilly and Company dividend yield?

The dividend yield of Eli Lilly and Company (LLY) is 0.61%

What is the Market Cap of Eli Lilly and Company?

The market capitalization of Eli Lilly and Company (LLY) is $815.93B

What is Eli Lilly and Company’s stock symbol?

The stock symbol (or ticker) of Eli Lilly and Company is LLY

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Global

India

Eli Lilly and Company, Common Stock

LLY

NYQ

$857.47

+$8.57

(1.01%)

Analyst Forecast

Price Chart

Key Metrics

52-week Range This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

About Eli Lilly and Company, Common Stock

Returns

Financials

Ratios

Liquidity

Asset Efficiency

Liabilities

Valuation

News

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

Feedback

Request to add more info/data

Inform about wrong info/data

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

Popular US Stocks ¹

Popular US ETFs ²